The concept of recovery in affective disorders

Psychotherapy and Psychosomatics

Volumn 65, Issue 1, 1996, Pages 2-13

  Fava, Giovanni A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; CONVALESCENCE; EDITORIAL; HUMAN; MAJOR DEPRESSION; MANIC DEPRESSIVE PSYCHOSIS; METHODOLOGY; OBSESSION; PANIC; PHOBIA; PREVENTIVE MEDICINE; PSYCHIATRY; RELAPSE; REMISSION;

EID: 0030061804     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000289025     Document Type: Article

References (160)

1. Frank E, Prien RF. Jarretl RB. Keller MB. Kupfer DJ. Lavori PW, Rush AJ. Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991:48:851-855.
2. Fava GA. Kellner R: Prodromal symptoms in affective disorders: AmJ Psychiatry 1991:148: 823-830.
3. Fava GA. Kellner R: Staging. A neglected dimension in psychiatric classification. Acta Psy-chiatrScand 1993;87:225-230.
4. Bech P: Measurement of psychological distress and well-being. Psychother Psychosom 1990: 54:77-89.
5. Feinstein AR: Clinimetrics. New Haven. Yale University Press, 1987.
6. Detre TP. Jarecki H: Modern Psychiatric Treatment. Philadelphia. Lippincott. 1971.
7. Fava GA, Grandi S. Canestrari R, Grasso P. Pesarin F: Mechanisms of change of panic attacks with exposure treatment of agoraphobia. J Affect Disord 1991:22:65-71.
8. Fava GA. Grandi S, Zielezny M. Canestrari R. Morphy MA: Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994:151:1295-1299.
9. Kellner R: The development of sensitive scales for research in therapeutics: in Fava M. Rosenbaum JF (eds): Research Design and Methods in Psychiatry. Amsterdam, Elsevier. 1992.
10. Fava GA: Measurement of prodromal and sub-clinical symptoms in mood and anxiety disorders: in Fava M. Rosenbaum JF (eds): Research Design and Methods in Psychiatry. Amsterdam, Elsevier. 1992.
11. Ryff CD: Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Pers Soc Psychol 1989:57:1069-1081.
12. Fava GA: The concept of psychosomatic disorder. Psychother Psychosom 1992:58:1-12.
13. Fava GA: Methodological and conceptual issues in research on quality of life. Psychother Psychosom 1990:54:70-76.
14. Peselow ED. Sanfilipo MP. Fieve RR. Gubel-kian G: Personality traits during depression and after clinical recovery. Br J Psychiatry 1994;164:349-354.
15. Fava M, Bouffides E. Pava JA, McCarthy MK. Steingard RJ. Rosenbaum JF: Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom 1994:62:160-167.
16. Fava GA. Kellner R. Zielezny M. Grandi S: Hypochondriacal fears and beliefs in agoraphobia. J Aftect Disord 1988:14:239-244.
17. Keith SJ. Matthews SM: The diagnosis of schizophrenia. Schizophr Bull 1991;17:51-67.
18. Donnelly EF. Murphy DL. Goodwin FK: Cross-sectional and longitudinal comparisons of bipolar and unipolar depressed groups on the MMPI. J Consult Clin Psychol 1976:44: 233-237.
19. Lumry AE, Gottesman II. Tuason VB: MMPI state dependency during the course of bipolar pyschosis. Psychiatry Res 1982:7:59-67.
20. MacVane JR. Lange JD. Brown WA. Zayat M: Psychological functioning of bipolar manic-depressives in remission. Arch Gen Psychiatry 1978:35:1351-1354.
21. Kerry RJ. Orne JE: Lithium, manic-depressive illness, and psychological test performance. Br Med J 1979;i:230.
22. Bouman TK. de Vries J. Doopmans IE: Lithium prophylaxis and interepisode mood. J Affect Disord 1992:24:199-206.
23. Fava GA. Molnar G. Spinks M, Loretan A, Bartlett D: Health attitudes and psychological distress in patients attending a lithium clinic. Acta Psychiatr Scand 1984:70:591-593.
24. Fava GA, Molnar G. Zielezny M. Loretan A. Spinks MT: Hostility and irritable mood during lithium prophylaxis. Med Sci Res 1987:15: 901-902.
25. Molnar G, Fava GA, Zielezny M. Spinks MT, Loretan A: Measurement of subclinical changes during lithium prophylaxis. Psychopathology 1987:20:155-161.
26. Goodnick PJ, Fieve RR. Schlegel A. Kaufman K: Interepisode major and subclinical symptoms in affective disorder. Acta Psychiatr Scand 1987;75:597-600.
27. Dion GL. Tohen M. Antony WA, Waternaux CS: Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 1988:39: 652-657.
28. Coryell W, Scheftner W, Keller MB. Endicott J, Maser J, Klerman GL: The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727.
29. Maj M. Pirozzi R. Kemali D: Long-term oul-comeof lithium prophylaxis in patients initially classified as complete responders. Psycho-pharmacology 1989;98:535-538.
30. Bauwens F. Tray A. Pardoen D. Vander Elst M, Mendlewicz J: Social adjustment of remitted bipolar and unipolar out-patients. Br J Psychiatry 1991:159:239-244.
31. Strakowski SM. Stoll AL. Tohen M. Faedda GL, Goodwin DC: The Tridimensional Personality Questionnaire as a predictor of six-month outcome in first episode mania. Psychiatry Res 1993:48:1-8.
32. Keller MB, Lavori PW. Kane JM. Gelenberg AJ. Rosenbaum JF. Walzcr EA, Baker LA: Sub-syndromal symptoms in bipolar disorder. Arch Gen Psychiatry 1992:49:371-376.
33. Paykel ES, Weissman MM: Social adjustment and depression. Arch Gen Psychiatry 1973:28: 659-664.
34. Goering PN. I.ancee WJ. Freeman SJJ: Mariial support and recovery from depression. Br J Psychiatry 1992:160:76-82.
35. Haves G, Rush AJ: Cognitive patterns in symptomatic and remitted unipolar major depression. J Abnorm Psychol 1984:93:31-40.
36. Williams JMG. Healv D, Teasdale JD. White W, Paykel ES: Dysfunctional attitudes and vulnerability to persistent depression. Psychol Med 1990:20:375-381.
37. Brown GW. Bifulco A. Andrews B: Self-esteem and depression. Soc Psychiatry Psychiatr Epidemiol 1990:25:244-249.
38. Power MJ. Duggan CE. Lee AS. Murray RM: Dysfunctional attitudes in depressed and recovered depressed patients and their first-degree relatives. Psychol Med 1995;25:87-93.
39. Scott J. Eccleston D, Boys R: Can we predict the persistence of depression? Br J Psychiatry 1992:161:633-637.
40. Murray LG. Blackburn IM: Personality differences in patients with depressive illness and anxiety neurosis. Acta Psychiatr Scand 1974: 50:183-191.
41. Altman JH. Witienborn JR: Depression-prone personality in women. J Abnorm Psychol 1980; 89:303-308.
42. Perris C, Eisemann M. von Knorring L. Perris H: Personality traits in former depression patients and in healthy subjects without past history of depression. Psychopathology 1984; 17: 178-186.
43. Clayton PJ. Ernst C. Angst J: Premorbid personality traits of men who develop unipolar or bipolar disorder. F.ur Arch Psychiatry Clin Ncurosci 1994;243:340-346.
44. Weissman MM, Kasl SV. Klerman GL: Follow-up of depressed women after maintenance treatment. Am J Psychiatry 1976:133:757-760.
45. Akiskal MS: Dysthymic disorder. Am J Psychiatry 1983:140:11-20.
46. Hirschfeld RMA. Klerman GL, Andreasen NC, Clayton PJ. Keller MB: Psycho-social predictors of chronicily in depressed patients. Br J Psychiatry 1986:148:648-654.
47. Mindham RM. Howland C. Shepherd M: An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 1973:3:5-17.
48. Faravelli C. Ambonetti A. Pallanti S. Pazzagli A: Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986; 143:888-891.
49. Prien RF. Kupfer DJ: Continuation drug therapy for major depressive episodes. Am J Psychiatry 1986;1743:18-23.
50. Gcorgotas A. McCue RE: Relapse of depressed patients after effective continuation therapy. J Affect Disord 1989;17:159-164.
51. Maj M. Veltro F. Pirozzi R. Lobracc S. Magliano L: Pattern of recurrence of illness after recovery from an episode of major depression. AmJ Psychiatry 1992:149:795-800.
52. Simons AD, Murphy GE. Levine JL, Wetzel RD: Cognitive therapy and pharmacotherapy of depression. Arch Gen Psychiatry 1986:43: 43-50.
53. Thase ME. Simons AD. McGeary J. Cabalane JF. Hughes C. Harden T. Friedman E: Relapse after cognitive behavior therapy of depression. Am J Psychiatry 1992:149:1046-1052.
54. Fava GA, Kellner R. Lisansky J. Park S, Perini GL Zielezny M: Rating depression in normals and depressives. J Affect Disord 1986:11:29-33.
55. Agosti V, Stewart JW. Quitkin FM, Ocepek-Welikson K: How symptomatic do depressed patients remain after benefiting from medication treatment? Comp Psychiatry 1993:34: 182-186.
56. Paykel ES: The Clinical Interview for Depression.,.1 Affect Disord 1985:9:85-96.
57. Fava GA. Grandi S, Canestrari R. Molnar G: Prodromal symptoms in primary major depressive disorder. J Affect Disord 1990; 19:149-152.
58. van Praag MM: About the centrality of mood lowering in mood disorders. Eur Neuropsycho-pharmacol 1992:2:393-404.
59. Fava GA, Sonino N: Hypothalamic-pituitary adrenal axis disturbances in depression. IRCS Med Sei 1986:14:1058-1061.
60. Ribeiro SCM, Tandon R. Grunhaus L, Greden JF: The DST as a predictor of outcome in depression. Am J Psychiatry 1993:150:1618-1629.
61. Wodarz N, Rupprecht R. Kornhuber J, Schmitz B. Wild K. Riederer P: Cell-mediated immunity and its glucocorticoid sensitivity after clinical recovery from severe major depressive disorder. J Affect Disord 1992;25:31-38.
62. Gillian JC. Wyatt RJ, Fram D, Snyder F: The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacolo-gv 1978:59:267-272.
63. Höchli D, Riemann D. Zully J. Berger M: Initial RF.M sleep suppression by clomipramine. Biol Psychiatry 1986:21:1217-1200.
64. Rieman D, Berger M: EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86. Neuropsychopharmacology 1989:2:145-152.
65. Buysse DJ, Kupfer DJ, Frank E, Monk TIL Rilenour A: Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy. Psychiatry Res 1992:40:27-40.
66. Thase ME, Reynolds CF, Frank E, Jennings JR. Nofzinger E. Fasiczka AL. Garamoni G. Kupfer DJ: Polysomnographie studies of unmedicated depressed men before and after cognitive behavioral therapy. Am J Psychiatry 1994:151:1615-1622.
67. Giles DE, Jarrell RB, Roffwarg HP. Rush AJ: Reduced REM latency. Neuropsychopharmacology 1987:1:51-59.
68. Reynolds CF. Perei JM. Frank E, ImberS. Thornton J. Morycz RK, Cornes C, Kupfer DJ: Open-trial maintenance pharmacotherapy in latelifc depression. Psychiatry Res 1989:27: 225-231.
69. Kupfer DJ, Frank E, McEachran AB, Grocho-cinsky VJ: Delta sleep ratio. Arch Gen Psychiatry 1990:47:1100-1105.
70. Hauri P. Chernik D. Hawkins D. Mendels.1: Sleep of depressed patients in remission. Arch Gen Psychiatry 1974;31:386-391.
71. Rush AJ. Erman MK, Giles DE. SchlesserMA, Carpenter G, Vasavada N. Roffward HP: Poly-somnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 1986:43:878-884.
72. Jarrett DB. Micwald JM. Kupfer DJ: Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion. Arch Gen Psychiatry 1990:47:113-118.
73. Kupfer DJ. Ehlers CL: Two roads to REM latency. Arch Gen Psychiatry 1989:46:945-948.
74. Rotschild AJ. Samson JA. Bond TC. Luciana MM. Schildkraut JJ. Schatzberg AF: Hvpotha-lamic-pituitary-adrenal axis activity and l-year outcome in depression. Biol Psychiatry 1993: 34:392-400.
75. Gurguis GNM. Mcador-Woodruff JH, Haskett RF. Greden JF: Multiplicity of depressive episodes. Biol Psychiatry 1990:27:1156-1164.
76. Keller MB. Yonkers KA. Warshaw MG. Pratt LA, Gollan JK, Massion AO, White K. Swartz AR. Reich J. Lavori PW: Remission and relapse in subjects with panic disorder and panic with agoraphobia. J Nerv Ment Dis 1994:182: 290-296.
77. Fava GA, Zielezny M, Savron G. Grandi S: Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995:166:87-92.
78. Katon W, Vitaliano PP. Anderson K, Jones M. Russo J: Panic disorder: Residual symptoms afferthe acute attacks abate. Compr Psychiatry 1987:28:151-158.
79. Faravelli C, Albanesi G: Agoraphobia with panic attacks. Compr Psvchiatry 1987:28:481-487.
80. Fava GA. Zielezny M. Luria E. Canestrari R: Obsessive-compulsive symptoms in panic disorder with agoraphobia. Psychiatry Res 1988; 23:57-63.
81. Noyes R. Clancy J. Woodman C, Hold CS, Suelzer M, Christiansen J, Anderson DJ: Environmental factors related to outcome of panic disorder. J Nerv Ment Dis 1993:181:529-538.
82. Schcibe G, Albus M: Prospective follow-up study lasting 2 years in patients w ith panic disorder with or without depressive disorders. Eur Arch Psychiatry Clin Neurosci 1994:244:39-44.
83. Mavissakalian M. Hamann MS: DSM-III personality characteristics of panic disorder with agoraphobia patients in stable remission. Compr Psychiatry 1992:33:305-309.
84. Saviotti FM. Grandi S. Savron G. Ermentini R. Bartolucci G. Conti S, Fava GA: Charactero-logical traits of recovered patients with panic disorder and agoraphobia. J Affect Disord 1991:23:113-117.
85. Fava GA. Grandi S, Canestrari R: Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry 1988;145:1564-1567.
86. Lelliotl P. Marks IM, McNamee G, Tobcna A: Onset of panic disorder with agoraphobia. Arch Gen Psychiatry 1989:46:1000-1004.
87. Fava GA. Grandi S. Rafanelli C. Canestrari R: Prodromal symptoms in panic disorder with agoraphobia. A replication study. J Affect Disord 1992;26:85-88.
88. Shear MK. Fyer AJ, Ball G. Josephson S. Fitzpatrick M. Giltlin B. Frances A, Gorman J, Uebowitz, M. Klein DF: Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. Am J Psychiatry 1991:148:795-797.
89. O'Sullivan G. Marks I: Long-term outcome of phobic and obsessive-compulsive disorders after treatment: in Noyes R. Roth M. Burrows GD (eds): Handbook of Anxiety, vol 4. Amsterdam, Elsevier. 1990.
90. Lelliott PT, Marks IM, Monteiro WO.Tsakir-is F, Noshirvani H: Agoraphobics 5 years after imipramine and exposure. J Nerv Ment Dis 1987:175:599-605.
91. Mavissakalian M, llamann MS. Jones B: DSM-III personality disorders in obsessive-compulsive disorder: Changes with treatment. Comp Psychiatry 1990:31:432-437.
92. Fava GA. Savron G. Rafanelli C. Grandi S. Canestrari R: Prodromal symptoms in obsessive-compulsive disorder. Psychopathology, in press.
93. McGarry PD: The concept of recovery and secondary prevention in psychotic disorders. Aust N ZJ Psychiatry 1992:26:3-17.
94. Haskell DS. di Mascio A. Prusoff B: Rapidity of symptom reduction in depressions treated with amitriptvline.,.J Nerv Ment Dis 1975: 160:24-33.
95. Katz MM. Koslow SH. Maas JW. Frazer A, Bowden CL. Casper R, Croughan J, Kocsis, I. Redmond, E: The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 1987:17:297-309.
96. Casper RC, Katz MM. Bowden CL. Davis JM, Hoslow SH. Hanin I: The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.,.J Affect Disord 1994:31:151-164.
97. Quitkin FM, Rabkin JG. Ross D. McGrath PJ: Duration of antidepressant drug treatment. What is an adequate trial? Arch Gen Psychiatry 1984:41:238-245.
98. Watkins JT. Leber WR. Imber SD. Collins JF. Elkin I, Pilkonis PA. Sotsky SM. Shea M l'. Glass DR: Temporal course of change of depression. J Consult Clin Psychol 1993:61: 858-864.
99. Rotschild R. Quitkin FM: Review of the use of pattern analysis to differentiate true drug and placebo responses. Psychother Psycho-som 1992:58:170-177.
100. Keller MB, Lavori PW. Mueller 11. Endicott J, Coryell W. Hirschfeld RMA. Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression. Arch Gen Psychiatry 1992:49:809-816.
101. Stassen HH. Delini-Stula A. Angst J: Time course of improvement under antidepressant treatment. Eur Neuropsychopharmacol 1993; 3:127-135.
102. Kopta SM. Howard KL Lowry JL. Bentler LE: Patterns of symptomatic recovery in psychotherapy. J Consult Clin Psychol 1994:62: 1009-1016.
103. Winokur G. Coryell W. Keller MB. Endicott J. Akiskal HS: A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993: 50:457-465.
104. Piccinelli M. Wilkinson G: Outcome of depression in psychiatric settings. Br.1 Psychiatry 1994;164:297-304.
105. Surtees PG. Barkley C: Future imperfect: The long-term outcome of depression. Br J Psychiatry 1994:164:327-341.
106. Ormel J. Oldehinkel T, Brilman E, Brink WV: Outcome of depression and anxiety in primary care. Arch Gen Psychiatry 1993:50:759-766.
107. Prien RF. Carpenter LL. Kupfer DJ: The definition and operational criteria for treatment outcome of major depressive disorder. Arch Gen Psychiatry 1991:48:796-800.
108. Phillips KA. Nierenberg AA: I he assessment and treatment of refractory depression. J Clin Psychiatry I994;55(suppl 2):20-26.
109. Silverstone T. Romans-Clarkson S: Bipolar affective disorder. BrJ Psychiatrv 1989; 154: 321-335.
110. Rosenbaum JF: Evaluation and management of the treatment-resistant anxiety disorder patient. Bull Menninger Clin 1992:56(suppl): A50-A60.
111. Shea MT. Elkin I, Imber S. Sostsky SM. Watkins JT, Collins JF, Pilkonis PA, Beckham E. Glass DR. Dolan RT. Parloff MB: Course of depressive symptoms over follow-up. Arch Gen Psychiatry 1992:49:782-787.
112. Bartlett JA. Schleifer SJ. Johnson RL, Keller SE: Depression in inner city adolescents attending an adolescent medicine clinic. J Ado-lesc Health 1991:12:316-318.
113. Wexler BE. Nelson JC: The treatment of major depressive disorders. Int J Mental Health 1993;22:7-41.
114. Gelder MG: Treatment of the neuroses. Int.1 Mental Health 1992;21:3-42.
115. Fava M. Kaji J: Continuation and maintenance treatments of major depressive disorder. Psychiatr Ann 1994:24:281-290.
116. Fava GA: Do antidepressant and antianxietv drugs increase chronicity in affective disorders? Psychother Psychosom 1994:61:125-131.
117. Baldessarini RJ: Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom 1995:63: 137-141.
118. Biondi M: Beyond the brain-mind dichotomy and toward a common organizing principle of pharmacological and psychological treatments. Psychother Psychosom 1995;64:1-8.
119. Fava GA: Holding on: depression, sensitization by antidepressant drugs, and the prodigal experts. Psychother Psychosom 1995:64:57-61.
120. Stewart J W. Mercier MA. Agosti V, Guardino M. Quitkin FM: Imipramine is effective after unsuccessful cognitive therapy. J Clin Psy-chopharmacol 1993:13:114-119.
121. Hoffart A. Due-Madsen J. Lande B, Gude T, Bille H. Torgersen S: Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy. J Clin Psychiatry 1993; 54:481-487.
122. Cole AJ, Brittlebank AD. Scott J: The role of cognitive therapy in refractory depression: in Nolen WA. Zohar J, RoseSP. Amsterdam JD (eds): Refractory Depression. Chichester, Wiley, 1994.
123. Pollack MH. Otto MW. Kaspi SP. Hammer-ncss PG, Rosenbaum JF: Cognitive-behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry 1994:55:200-205.
124. Tamer RN, Beckett R. Harwood S. Baker A. Yusupoff L, Ugarteburn I: A trial of two cognitive-behavioral methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients. BrJ Psychiatry 1993; 162:524-532.
125. Emmelkamp PMG, Bouman TK. Scholing A: Anxiety Disorders. Chichester. Wiley, 1992.
126. Scholing A. Emmelkamp PMG: Cognitive and behavioral treatments of fear of blushing, sweating or trembling. Behav Rcs Ther 1993; 31:155-170.
127. Pava JA. Fava M, Levenson JA: Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression. Psychother Psychosom 1994:61:211-219.
128. Weissman MM. Klerman GL. Paykel ES. Prusoff B. Hanson B: Treatment effects on social adjustment of depressed patients. Arch Gen Psychiatry 1974;30:771-778.
129. Kupfer DJ: Maintenance treatment in recurrent depression. Br J Psychiatry 1992:161: 309-316.
130. Beitman BD: Pharmacotherapy and the stages of psychotherapeutic change; in Oldham JM, Riba MB, Tasman A (eds): Annual Review of Psychiatry. Washington. American Psychiatric Press. 1993.
131. Brown ES. Disalver SC. Shoaib AM, Swann AC: Depressive mania: Response of residual depression to bupropion. Biol Psychiatry 1994:35:493-494.
132. lloencamp E, Haffmans PMJ. Duivern-voorden H. Knegtering H. Dijken WA: Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy. J Affect Disord 1994:31: 235-246.
133. Deakin JFW: The clinical anxiolytic and antidepressant efficacy of drugs with actions on serotonin systems: in den Boer JA. Sitsen JM (eds): Handbook of Depression and Anxiety. New York. Dekker. 1994.
134. Bakish D, Lapierre YD, Weinstein R. Klein J, Wiens A. Jones B. Horn E. Browne M. Bourget D, Blanchard A. Thibaudeau C. Waddell C. Raine D: Ritanscrin, imipramine, and placebo in the treatment of dysthymic disorder. J Clin Psychopharmacol 1993:13:409-414.
135. Sonino N. Boscaro M. Fallo F. Fava GA: Potential therapeutic effects of ritanserin in Cushing's disease. JAMA 1992:267:1073.
136. Kishimoto A. Mizukawa R. Matsuzaki F. Ha-zama H, Karnase II. Tanaka K. Kunimoto N: Prophylatic effect of mianserin on recurrent depression. Acta Psychiatr Scand I994;89: 46-51.
137. Rvff CD. Singer B: Psychological well-being: Meaning, measurement, and implications for psychotherapy research. Psychother Psycho-som 1996:65:14-23.
138. Sam DM. Green B. Power MJ. Checkley S: The impact of social cognitive variables on the initial level of depression and recovery.,.J Affect Disord 1994:32:75-83.
139. Andrews B, Brown GW: Stability and change in low self-esteem. Psychol Med 1995,25:25-31.
140. Leenstra AS, Orntel J, Giel R: Positive life change and recovery from depression and anxiety. Br J Psychiatry 1995:166:333-343.
141. Thunedborg K. Black CH, Bech P: Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients: Prediction of recurrence of depression by quality of life measurements. Psychother Psy-chosom 1995:64:131-140.
142. Kellner R. Rada RT, Andersen T. Pathak D: The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being. Psychopharmacology 1979:64:185-191.
143. Maser JD, Cloninger G (eds): Comorbidity of Mood and Anxiety Disorders. Washington. American Psychiatric Press. 1990.
144. Carroll BJ: Neurobiologie dimensions of depression and mania: in Angst J (ed): The Origins of Depression. Berlin. Springer. 1983.
145. Van Praag MM, Asms GM. Kahn RS. Brown ST, Korn M. Friedman JMH, Wetzler S: Monoamines and abnormal behaviour. Br.1 Psychiatry 1990:157:723-734.
146. De Leon J, Wilson WH, Simpson GM: Negative symptoms, defect state and Huber’s basic symptoms. PsychiatrQ 1991:62:277-298.
147. Manu P. Matthews DA, Lane TJ. Tennen H. Hesselbrock V, Mendola R. Affleck G: Depression among patients with a chief complaint of chronic fatigue. J Affect Disord 1989:17:165-172.
148. Paykel FS: Epidemiology of refractory' depression: in Nolen WA. Wohar J. Rose SP. Amsterdam JD (eds): Refractory Depression. Chichester, Wiley, 1994.
149. Roth M. Bames TRE: The classification of affective disorders. Comp Psychiatry 1981: 22:54-77.
150. Foulds GA: The significance of intra-individual diagnostic levels. Br J Psychiatry 1965; 111:761-768.
151. Surtees PG. Kendcll RE: The hierarchy model of psychiatric symptomatology. Br J Psychiatry 1979:135:438-443.
152. Goekopp JG, Zwinderman AH: Multidimensional hierarchic ordering of psychopathology. Acta Psychiatr Scand 1994:90:399-404.
153. Feighner JP. Robins E. Guze SB, Woodruff RA, Winokur G. Munoz R: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972:26:57-63.
154. Fava GA. Freyberger HJ. Bech P, Christo-doulou G. Sensky T, Theorell T. Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995:63: 1-8.
155. Rice JKP. Rochberg N. Endicott J, Lavori P. Miller C: Stability of psychiatric diagnoses. Arch Gen Psychiatry 1992:49:824-830.
156. Clayton PJ. Guze SB. Cloninger CR. Martin RL: Unipolar depression. J Affect Disord 1992;26:111-116.
157. Turner SM. Beidel DC. Long PJ. Turner MW. Townslev RM: A composite measure to determine the functional status of treated social phobics. Bchav Titer 1993:24:265-275.
158. Taylor S. McLean P: Outcome profiles in the treatment of unipolar depression. Behav Res Thcr 1993:31:325-330.
159. Fava GA: The concept of neurosis. A reassessment is overdue. Psychother Psychosom 1993:59:113-115.
160. Imbodcn JB, Canter A, Clul'f LE: Convalescence from influenza. Arch Intern Med 1961: 108:393-399.